Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 1

Status

Recruiting 3Terminated 2

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Breast Neoplasms 425Carcinoma, Non-Small-Cell Lung 356Neoplasms 324Prostatic Neoplasms 278Colorectal Neoplasms 253Multiple Myeloma 203Lung Neoplasms 194Neoplasm Metastasis 175Leukemia, Myeloid, Acute 165Pancreatic Neoplasms 148Ovarian Neoplasms 141Squamous Cell Carcinoma of Head and Neck 134Melanoma 120Recurrence 102Carcinoma, Renal Cell 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 96Head and Neck Neoplasms 94Lymphoma, Non-Hodgkin 93Glioblastoma 92Carcinoma, Hepatocellular 92Lymphoma 90Endometrial Neoplasms 90Stomach Neoplasms 87Triple Negative Breast Neoplasms 85Brain Neoplasms 83Lymphoma, Large B-Cell, Diffuse 79Uterine Cervical Neoplasms 75Urinary Bladder Neoplasms 75Glioma 70Leukemia, Lymphocytic, Chronic, B-Cell 69

Interventions

pembrolizumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Solid Tumor, Adult × 30 days × Clear all
NCT06977737 2026-05-22

ATTEST

Accession Therapeutics Limited

Phase 1/2 Recruiting
72 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT06265688 2026-05-19

First In Human Study of CX-2051 in Advanced Solid Tumors

CytomX Therapeutics

Phase 1 Recruiting
160 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT06462794 2026-05-15

First In Human Study of CX-801 in Advanced Solid Tumors

CytomX Therapeutics

Phase 1 Recruiting
121 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT05582850 2026-05-12

EPRAD

Domain Therapeutics SA

Phase 1 Terminated
29 enrolled 12 charts
Other solid neoplasm

Solid Tumor, Adult

NCT07159828 2026-05-06

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Instil Bio

Phase 1 Terminated
3 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡